Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Evoked Potentials, Visual | 4 | 2018 | 40 | 2.24 | Why? |
| Optic Nerve | 2 | 2018 | 123 | 1.35 | Why? |
| Optic Neuritis | 2 | 2019 | 132 | 1.32 | Why? |
| Retina | 4 | 2019 | 424 | 1.22 | Why? |
| Multiple Sclerosis, Chronic Progressive | 3 | 2018 | 136 | 0.92 | Why? |
| Multiple Sclerosis | 9 | 2020 | 2600 | 0.85 | Why? |
| Axons | 2 | 2017 | 73 | 0.85 | Why? |
| Visual Pathways | 1 | 2018 | 21 | 0.74 | Why? |
| Epidermis | 1 | 2018 | 47 | 0.72 | Why? |
| Neuromyelitis Optica | 2 | 2019 | 397 | 0.66 | Why? |
| Frontotemporal Dementia | 1 | 2017 | 55 | 0.64 | Why? |
| Stroke Rehabilitation | 2 | 2021 | 299 | 0.58 | Why? |
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2020 | 529 | 0.57 | Why? |
| Motor Skills | 1 | 2014 | 57 | 0.53 | Why? |
| Transcranial Magnetic Stimulation | 1 | 2014 | 160 | 0.48 | Why? |
| Alzheimer Disease | 2 | 2019 | 1020 | 0.41 | Why? |
| Lower Extremity | 1 | 2014 | 593 | 0.37 | Why? |
| Tomography, Optical Coherence | 3 | 2019 | 1008 | 0.31 | Why? |
| Cognitive Dysfunction | 1 | 2017 | 1389 | 0.29 | Why? |
| Neurology | 3 | 2021 | 1613 | 0.27 | Why? |
| Disability Evaluation | 2 | 2020 | 671 | 0.26 | Why? |
| Telemedicine | 10 | 2021 | 25032 | 0.23 | Why? |
| Genetic Vectors | 2 | 2018 | 1600 | 0.21 | Why? |
| Rhodopsin | 1 | 2018 | 4 | 0.19 | Why? |
| Electroretinography | 1 | 2018 | 26 | 0.19 | Why? |
| Methyl Ethers | 1 | 2018 | 22 | 0.18 | Why? |
| Gene Targeting | 1 | 2018 | 34 | 0.18 | Why? |
| Retinal Degeneration | 1 | 2018 | 20 | 0.18 | Why? |
| Photic Stimulation | 1 | 2018 | 74 | 0.18 | Why? |
| beta-Glucosidase | 1 | 2017 | 7 | 0.18 | Why? |
| Long-Term Potentiation | 1 | 2017 | 19 | 0.18 | Why? |
| tau Proteins | 1 | 2019 | 162 | 0.18 | Why? |
| Evoked Potentials | 1 | 2017 | 44 | 0.17 | Why? |
| Neuromuscular Diseases | 1 | 2021 | 303 | 0.17 | Why? |
| Electrodes | 1 | 2018 | 203 | 0.17 | Why? |
| Atrophy | 1 | 2017 | 192 | 0.17 | Why? |
| Amyloid beta-Peptides | 1 | 2019 | 185 | 0.17 | Why? |
| Anesthetics, Inhalation | 1 | 2018 | 82 | 0.16 | Why? |
| Monitoring, Ambulatory | 1 | 2020 | 343 | 0.16 | Why? |
| Dependovirus | 1 | 2017 | 272 | 0.16 | Why? |
| Adenosine Deaminase | 1 | 2017 | 85 | 0.16 | Why? |
| Wearable Electronic Devices | 2 | 2020 | 694 | 0.15 | Why? |
| Mental Status and Dementia Tests | 1 | 2017 | 208 | 0.15 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.15 | Why? |
| Myasthenia Gravis | 1 | 2021 | 385 | 0.15 | Why? |
| Stroke | 2 | 2021 | 8839 | 0.15 | Why? |
| Amyotrophic Lateral Sclerosis | 1 | 2020 | 398 | 0.14 | Why? |
| Vision Disorders | 1 | 2018 | 260 | 0.14 | Why? |
| Family Health | 1 | 2018 | 731 | 0.12 | Why? |
| Adenosine | 1 | 2017 | 509 | 0.12 | Why? |
| Smartphone | 2 | 2020 | 1840 | 0.12 | Why? |
| Social Networking | 1 | 2018 | 737 | 0.11 | Why? |
| Biomarkers | 4 | 2019 | 23361 | 0.11 | Why? |
| Reference Values | 1 | 2014 | 795 | 0.11 | Why? |
| Data Collection | 1 | 2020 | 1769 | 0.11 | Why? |
| Cross-Over Studies | 1 | 2014 | 867 | 0.11 | Why? |
| Analysis of Variance | 1 | 2014 | 950 | 0.10 | Why? |
| Rats | 1 | 2018 | 2764 | 0.10 | Why? |
| Continuity of Patient Care | 1 | 2020 | 1574 | 0.10 | Why? |
| Needs Assessment | 1 | 2020 | 2352 | 0.10 | Why? |
| Walking | 1 | 2014 | 442 | 0.10 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.10 | Why? |
| Exercise Therapy | 1 | 2017 | 976 | 0.09 | Why? |
| Brain | 4 | 2018 | 5133 | 0.09 | Why? |
| Parkinson Disease | 1 | 2020 | 1414 | 0.09 | Why? |
| Epilepsy | 1 | 2020 | 1401 | 0.09 | Why? |
| Recovery of Function | 2 | 2017 | 2461 | 0.08 | Why? |
| Gene Expression | 1 | 2017 | 3332 | 0.08 | Why? |
| Dementia | 1 | 2020 | 1861 | 0.08 | Why? |
| Longitudinal Studies | 2 | 2020 | 9893 | 0.08 | Why? |
| Magnetic Resonance Imaging | 2 | 2017 | 6551 | 0.07 | Why? |
| Humans | 26 | 2021 | 930598 | 0.06 | Why? |
| Genetic Therapy | 2 | 2018 | 409 | 0.06 | Why? |
| Double-Blind Method | 1 | 2014 | 5988 | 0.06 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.06 | Why? |
| Pilot Projects | 1 | 2014 | 5182 | 0.06 | Why? |
| Disease Progression | 2 | 2018 | 13580 | 0.06 | Why? |
| Female | 11 | 2020 | 380317 | 0.06 | Why? |
| Electroencephalography | 2 | 2018 | 1242 | 0.05 | Why? |
| Mice, Transgenic | 2 | 2018 | 2739 | 0.05 | Why? |
| Social Isolation | 1 | 2020 | 5932 | 0.05 | Why? |
| Internet | 1 | 2018 | 6204 | 0.05 | Why? |
| Alemtuzumab | 1 | 2020 | 121 | 0.05 | Why? |
| Chronic Disease | 1 | 2014 | 5139 | 0.05 | Why? |
| Mice, Mutant Strains | 1 | 2018 | 42 | 0.05 | Why? |
| Electroporation | 1 | 2018 | 52 | 0.05 | Why? |
| Evoked Potentials, Somatosensory | 1 | 2017 | 40 | 0.04 | Why? |
| Electrophysiological Phenomena | 1 | 2017 | 59 | 0.04 | Why? |
| Animals | 5 | 2018 | 78931 | 0.04 | Why? |
| Nervous System Diseases | 1 | 2017 | 4092 | 0.04 | Why? |
| Gene Order | 1 | 2017 | 144 | 0.04 | Why? |
| alpha-Synuclein | 1 | 2017 | 71 | 0.04 | Why? |
| Male | 8 | 2020 | 367725 | 0.04 | Why? |
| Spinal Cord | 1 | 2018 | 281 | 0.04 | Why? |
| Gene Transfer Techniques | 1 | 2017 | 134 | 0.04 | Why? |
| Transduction, Genetic | 1 | 2017 | 273 | 0.04 | Why? |
| Neurofilament Proteins | 1 | 2017 | 202 | 0.04 | Why? |
| RNA, Guide | 1 | 2018 | 269 | 0.04 | Why? |
| Tumor Suppressor Proteins | 1 | 2017 | 165 | 0.04 | Why? |
| Behavior, Animal | 1 | 2017 | 136 | 0.04 | Why? |
| Enzyme Activation | 1 | 2017 | 425 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Italy | 4 | 2021 | 38444 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2014 | 17020 | 0.04 | Why? |
| Age of Onset | 1 | 2017 | 557 | 0.04 | Why? |
| Behavior | 1 | 2017 | 252 | 0.03 | Why? |
| Fibroblasts | 1 | 2018 | 839 | 0.03 | Why? |
| Histocompatibility Antigens Class I | 1 | 2018 | 624 | 0.03 | Why? |
| Blood-Brain Barrier | 1 | 2017 | 531 | 0.03 | Why? |
| Denmark | 1 | 2020 | 2654 | 0.03 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.03 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Adult | 6 | 2020 | 244371 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Middle Aged | 6 | 2020 | 270681 | 0.03 | Why? |
| Netherlands | 1 | 2020 | 3533 | 0.03 | Why? |
| Neurons | 1 | 2017 | 864 | 0.03 | Why? |
| Time Factors | 1 | 2014 | 31397 | 0.03 | Why? |
| Aged | 4 | 2020 | 215776 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| CRISPR-Cas Systems | 1 | 2018 | 1397 | 0.02 | Why? |
| Mutation | 2 | 2018 | 12376 | 0.02 | Why? |
| Body Mass Index | 1 | 2020 | 4306 | 0.02 | Why? |
| Mice | 2 | 2017 | 21357 | 0.02 | Why? |
| Treatment Outcome | 1 | 2014 | 51732 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.02 | Why? |
| Mobile Applications | 1 | 2020 | 3032 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.02 | Why? |
| HEK293 Cells | 1 | 2018 | 8394 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2019 | 7220 | 0.02 | Why? |
| Europe | 1 | 2020 | 12702 | 0.02 | Why? |
| Spain | 1 | 2020 | 15545 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Social Media | 1 | 2020 | 5798 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2017 | 7330 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Delivery of Health Care | 1 | 2018 | 15909 | 0.01 | Why? |
| Adolescent | 1 | 2020 | 86841 | 0.01 | Why? |
| Retrospective Studies | 1 | 2019 | 105322 | 0.01 | Why? |
Leocani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(145)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_